Positive              

• Diagnosis of the disease up to 10 years before current technology allows

• Patients can undergo medicinal treatments earlier, potentially slowing the progression of the disease

• PACI provides scientists with clinical trials to move closer towards developing a cure

                       Negative
The radioactive biomarker florbetapir may have unknown impacts on a patient

• Breastfeeding 24 hours after dosage may put a child at risk
  
• Each dose can cost up to $1,800 per dose